APA (7th ed.) Citation

Nangia-Makker, P., Ahrens, M., Purandare, N., Aras, S., Li, J., Gurdziel, K., . . . Shekhar, M. P. Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. MDPI AG.

Chicago Style (17th ed.) Citation

Nangia-Makker, Pratima, Madison Ahrens, Neeraja Purandare, Siddhesh Aras, Jing Li, Katherine Gurdziel, Hyejeong Jang, Seongho Kim, and Malathy P. Shekhar. Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. MDPI AG.

MLA (9th ed.) Citation

Nangia-Makker, Pratima, et al. Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. MDPI AG.